Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Fell 1.45% to 14.320
Newtimespace News, as of 10:19 on May 14, Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) was quoted at HKD 14.320, down 1.45%. The ETF opened at HKD 14.830, with a high of HKD 14.830 and a low of HKD 14.320. The latest NAV per unit is HKD 14.567, with a premium rate of -0.25%. The asset size is approximately HKD 2.261 billion.
Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of biotechnology companies listed in Hong Kong, covering companies in areas such as pharmaceuticals, biotechnology, and medical equipment. It serves as one of the important market benchmarks for gauging the performance of Hong Kong's biotechnology sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CapitaLand Ascendas REIT Officially Launches S$1.4 Billion Geneo Project to Revitalise Singapore Science Park
- Daily Report on Hong Kong-Listed LLM Concept Stocks (May 22, 2026)
- Large Model Concept Stocks Volatility: Intensive Product Releases and Comprehensive Multi-functional Application Landscape Unfold
- Diagens-B (02526.HK): Core Product AI AutoVision® Obtains NMPA Class III Medical Device Registration Certificate
- Samsung Blockchain Technologies ETF (03171.HK) Rises 3.35% to HKD 48.100